IDEXX Laboratories Q1 2025 Update
Ticker: IDXX · Form: 10-Q · Filed: May 1, 2025 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, diagnostics
TL;DR
IDEXX Q1 2025: Financials are in. Check the balance sheet for AP & accrued liabilities.
AI Summary
IDEXX Laboratories Inc. reported its first quarter 2025 results for the period ending March 31, 2025. The company's financial statements show key figures related to its operations, including product and service revenues, and balance sheet items like accounts payable and accrued liabilities.
Why It Matters
This filing provides investors with a quarterly update on IDEXX's financial performance, crucial for understanding the company's ongoing health and market position in the diagnostics sector.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks disclosed.
Key Numbers
- 2025-03-31 — Reporting Period End (Quarterly financial reporting)
- 2025-01-01 — Reporting Period Start (Quarterly financial reporting)
- 2024-12-31 — Prior Year End (Comparison for financial analysis)
Key Players & Entities
- IDEXX LABORATORIES INC /DE (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250501 (date) — Filing Date
- WESTBROOK, ME (location) — Company Headquarters
FAQ
What were IDEXX's total revenues for the first quarter of 2025?
The filing does not explicitly state total revenues for Q1 2025, but provides segment revenues for 'Product' and 'Service' for the periods ending March 31, 2025, and March 31, 2024.
What is the company's reported Accounts Payable as of March 31, 2025?
The filing references 'AccountsPayableCurrent' but does not provide a specific dollar amount for March 31, 2025, within the provided text.
What is the company's reported Accrued Liabilities as of March 31, 2025?
The filing references 'AccruedLiabilitiesCurrent' but does not provide a specific dollar amount for March 31, 2025, within the provided text.
What is the fiscal year end for IDEXX Laboratories?
The fiscal year end for IDEXX Laboratories is December 31.
What is the Standard Industrial Classification (SIC) code for IDEXX Laboratories?
The SIC code for IDEXX Laboratories is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding IDEXX LABORATORIES INC /DE (IDXX).